Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
BlackRock Global Dividend Inv C BCBDX
- NAV / 1-Day Return 11.95 / +0.08 %
- Total Assets 1.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.820%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Global Large-Stock Value
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.95%
- Turnover 53%
USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 10:14 PM GMT+0
Morningstar’s Analysis BCBDX
Will BCBDX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Microsoft Corp | 5.10 | 67.0 Mil | Technology |
AbbVie Inc | 3.04 | 40.0 Mil | Healthcare |
Novo Nordisk A/S Class B | 2.95 | 38.8 Mil | Healthcare |
Taiwan Semiconductor Manufacturing Co Ltd | 2.93 | 38.5 Mil | Technology |
AstraZeneca PLC | 2.84 | 37.3 Mil | Healthcare |
UnitedHealth Group Inc | 2.80 | 36.8 Mil | Healthcare |
Apple Inc | 2.61 | 34.4 Mil | Technology |
RELX PLC | 2.56 | 33.7 Mil | Industrials |
Nestle SA | 2.51 | 33.0 Mil | Consumer Defensive |
Texas Instruments Inc | 2.51 | 33.0 Mil | Technology |